Alerts will be sent to your verified email
Verify Email
BOSTON BIO
|
Laser Eyecare
|
Transpact Enterprise
|
GKB Ophthalmics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.46 % | -25.32 % | -3.59 % |
|
5yr average Equity Multiplier
|
1.61 | 1.69 | 1.98 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.11 | 0.67 |
|
5yr Avg Net Profit Margin
|
0.0 | -84.24 % | -1.93 % |
|
Price to Book
|
1.02 | 0.0 | 0.75 |
|
P/E
|
0.0 | 740.8 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 61.76 Days |
|
Inventory Days
|
0.0 | 581.35 Days | 179.68 Days |
|
Days Receivable
|
0.0 | 0.0 | 90.24 Days |
|
Days Payable
|
0.0 | 94.84 Days | 195.73 Days |
|
5yr Average Interest Coverage Ratio
|
-6.56 | -2283.06 | 0.33 |
|
5yr Avg ROCE
|
-0.45 % | -24.21 % | 0.11 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -68.42 % | 2.64 % |
|
5 yr average Debt to Equity
|
0.13 | 0.36 | 0.21 |
|
5yr CAGR Net Profit
|
n/a | -26.86 % | 50.56 % |
|
5yr Average Return on Assets
|
-0.28 % | -15.61 % | -1.54 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
2.14 % | 16.16 % | 51.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -29.73 % | -8.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Laser Eyecare
|
Transpact Enterprise
|
GKB Ophthalmics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|